Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis - Related Studies

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)

This study is currently recruiting participants.

Study NCT00629642. Last updated on September 24, 2008. Information provided by Astellas Pharma Inc

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neurogenic Bladder
		Spinal Cord Diseases
		Multiple Sclerosis

2	Additional conditions recognized in this trial
		Sclerosis
		Urinary Bladder, Neurogenic

3	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Central Nervous System Diseases
		Demyelinating Autoimmune Diseases, CNS
		Demyelinating Diseases
		Immune System Diseases
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms
		Urinary Bladder Diseases
		Urologic Diseases

4	Interventions listed in this trial
		Solifenacin Succinate
		Oxybutynin Hydrochloride
		Placebo

5	Additional drug interventions recognized in this trial
		Mandelic Acids
		Oxybutynin
		Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Anti-Infective Agents, Urinary
		Autonomic Agents
		Cholinergic Agents
		Cholinergic Antagonists
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Parasympatholytics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Renal Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Astellas Pharma Inc